Abstract Case report is presented, which describes a patient with thromboemboli trapped in the Chiari network within the right heart and resistant to thrombolysis. The right atrial masses were completely removed under cardiopulmonary bypass. Histological evaluation confirmed a mixed thromboemboli, with thrombus structures showing signs of organization and surrounded by a fibrous capsule. A heterozygous methylenetetrahydrofolate reductase gene polymorphism was found, and the plasma level of the plasminogen activator inhibitor type-1 (PAI-1) was 50% higher than the normal upper limit. In this presented case, the Chiari network displayed a protective function, but the expansion and organization of the thromboembolus caught there made it resistant to lytic therapy. Another important factor which could have influenced the resistance to thrombolysis was the high level of PAI-1. PAI-1 is the primary physiologic inhibitor of plasminogen activation in blood. Elevated pre-treatment levels of PAI-1 may reduce the efficacy of thrombolytic therapy by preventing or retarding clot dissolution. The patient's DNA was tested for a common single-base-pair polymorphism (four or five guanine bases) in the promoter region of the gene (4G/5G), but the presence of this variant allele was not confirmed: the patient was homozygous for the 5G allele (5G/5G genotype).
Introduction
The echocardiographic presence of right heart thromboemboli during a pulmonary embolism is described in the literature as occurring in about 4% of patients, with a high related rate of massive pulmonary embolism and short-term mortality [1, 2] . Unfortunately, there is no consensus regarding the treatment strategy for such patients. Favourable results, however, have been reported with thrombolysis [3] .
Here, a well-documented case report is presented, which describes a patient with thromboemboli trapped in the Chiari network within the right heart and resistant to thrombolysis.
Case report
A 43-year-old woman presented in hospital with pain and asymmetric swelling of her left leg, which had been Electronic supplementary material The online version of this article (doi:10.1007/s11239-009-0403-6) contains supplementary material, which is available to authorized users.
accompanied by shortness of breath during physical activity over the previous 2 weeks. At presentation, she was a smoker and had a long history of taking contraceptive medication; and she was on substitution therapy for hypothyreosis. Her history also included two spontaneous abortions. The previous year, she had been hospitalized for pyelonephritis complicated by septic shock; during this hospital stay the patient underwent transthoracic echocardiography where a Chiari network in the right atrium was found. The patient's mother had suffered from a postoperative pulmonary embolism at the age of 50 years.
On physical examination, the patient was stable with a BP of 140/80 mmHg, HR 80 bpm; her height was 165 cm and weight was 68 kg. Except for the left-leg edema, with positive Homan's sign, there were no other pathological findings. No signs of right heart failure were present. A laboratory blood examination found D-dimers, mild leukocytosis and above normal levels of CRP. A ventilationperfusion lung scan confirmed a bilateral pulmonary embolism. The source of the embolus was established by Doppler ultrasonography, which documented a femoralpopliteal venous thrombosis in the left leg.
The patient was haemodynamically stable, so treatment with a full-anticoagulation dose of unfractioned heparin (UFH) was started. A transthoracic echocardiography was performed, which showed two large stationary masses within the right atrium. Their structure and density were suggestive of emboli ( Fig. 1 , Video 1 in Supplementray Material). One mass was protruding from the right atrium through the tricuspid valve into the right ventricle, but without causing a gradient; systolic functions of both ventricles were normal, and there were no signs of right heart overload. Transesophageal echocardiography described the hypoechogenic masses as well-circumscribed (23 9 15 mm and 14 9 20 mm) with homogenous structure. The masses appeared to stem from the posterior wall of the right atrium and were caught in the Chiari network (Video 2 in Supplementray Material).
Both structures were assessed as thromboemboli lodged in the right atrium. Thrombolytic therapy with an IV infusion of 100 mg rt-PA, over a period of 2 h, with continuous echocardiographic monitoring was performed. Following rt-PA treatment, full dose UFH was restarted. In subsequent control echocardiographies, the two masses found to persist without any change in their shape or size. Magnetic resonance imaging further confirmed the thromboembolic etiology of these right atrial masses (Fig. 2) . With respect to the high risk of a fatal pulmonary embolism and the inefficacy of the most potent lytic strategy, surgical embolectomy was indicated. Preoperatively, a control Doppler ultrasonography documented the persistence of thrombotic materials in the veins of the left leg. Therefore, a temporary inferior vena cava filter was implanted prior to surgery.
The right atrial masses were completely removed under cardiopulmonary bypass (Fig. 3) . Histological evaluation confirmed a mixed thromboemboli, with thrombus structures showing signs of organization and surrounded by a fibrous capsule (Fig. 4) .
The patient, with a positive family history of pulmonary embolism, had further known risk factors for venous thromboembolism i.e. cigarette smoking and use of oral contraceptive. Because of the high suspicion of thrombophilia, the patient was tested for thrombophilic disorders (Table 1) . A heterozygous methylenetetrahydrofolate reductase gene polymorphism was found, and the plasma level of the plasminogen activator inhibitor type-1 (PAI-1) was 50% higher than the normal upper limit.
The patient was discharged home in good condition. She was placed on standard warfarin anticoagulation therapy. The patient also stopped cigarette smoking and discontinued contraceptive therapy. One month after discharge, a control angiography of the vena cava showed persistence of thrombotic masses, so the preoperatively implanted temporary vena cava filter was replaced by a permanent one.
Discussion
Chiari anomalies in the human right atrium have been detected in 10.5% of autopsied hearts [4] . The Chiari network is a web-like structure with a variable number of thread-like components. It is an embryologic remnant, resulting from the incomplete resorption of the right sinus venosus valve and persistence of a filamentous tissue network [5] . These filaments are attached to the wall of the right atrium in close proximity to the entrance of the inferior vena cava [4] . Chiari malformation is not pathological and is rarely of clinical importance [5, 6] . The spider-web-like structure predisposes it to act as a filter for the inferior vena cava [7] . However, the Chiari network can serve as a site of thrombus formation and also as a site where an embolus from the inferior vena cava can become lodged. Endocarditis which develops solely within a Chiari network has been described as well [8] .
In this presented case, the Chiari network displayed a protective function, but the expansion and organization of the thromboembolus caught there made it resistant to lytic therapy. Another important factor which could have influenced the resistance to thrombolysis was the high level of PAI-1. PAI-1 is the primary physiologic inhibitor of plasminogen activation in blood. When PAI-1 plasma levels are elevated, the action of t-PA is depressed [9] , resulting in thromboembolic disorders [10] . In addition, elevated pre-treatment levels of PAI-1 may reduce the efficacy of thrombolytic therapy by preventing or retarding clot dissolution [11] .
The influence of impaired glucose metabolism or lipid disorders on PAI-1 plasma concentration was excluded in this patient. PAI-1 plasma levels partly depend on gene regulation [9, 12] . At present, however, genetic and environmental determinants of PAI-1 expression are incompletely understood [13] . The human PAI-1 gene is located on chromosome 7 and contains nine exons and eight introns [12] , and several polymorphisms have been described within the gene. The patient's DNA was tested for a common single-base-pair polymorphism (four or five guanine bases) in the promoter region of the gene (4G/5G), but the presence of MTHFR methylenetetrahydrofolate reductase this variant allele was not confirmed: the patient was homozygous for the 5G allele (5G/5G genotype). Unsuccessful results with thrombolysis have been described in 8% of patients with an acute massive pulmonary embolism [14] . In these patients, emergency surgical embolectomies have led to better in-hospital outcomes when compared with repeated thrombolysis attempts [14] . In cases where a patient, after surgical embolectomy, is at increased risk for recurrent pulmonary embolism, the insertion of a vena cava filter is of potential benefit [15] .
Conclusion
The Chiari network may help prevent massive pulmonary embolisms through filtration of blood from the inferior vena cava. In the presented case, because of the combination of the thromboembolus and concomitant elevation of PAI-1, which increased the probability of thrombolytic failure, this embryologic remnant might have been a lifesaving structure. 
